Targeted disruption of translation for nut carcinoma
Active Project Grant Awarded Last action
- Award ID
- HT9425261E456
- Recipient
-
Mayo Clinic UEI Y2K4F9RPRRG7 Part of Mayo Clinic
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $140,000
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date 0% complete
- Place of performance
- Rochester, MN 55905, USA
Award details come from USAspending.gov.
About this award
The Defense Health Agency awarded Mayo Clinic $140,000 on November 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to conduct targeted disruption of translation for NUT carcinoma. Work is performed in Rochester, Minnesota, with an expected completion date of October 31, 2028. The award supports basic and applied biomedical research intended to transform healthcare for Service Members and the American public through innovative research and investigation of medical solutions relevant to military health priorities.
Quick answers
Who received award HT9425261E456?
HT9425261E456 was awarded to Mayo Clinic by Defense Health Agency (Department of Defense) on November 1, 2026.
How much is award HT9425261E456 worth?
$140,000 has been obligated on HT9425261E456.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award